Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
Research Article

Development and validation of a potent and specific inhibitor for the CLC-2 chloride channel

View ORCID ProfileAnna K. Koster, View ORCID ProfileAustin L. Reese, Yuri Kuryshev, Xianlan Wen, View ORCID ProfileKeri A. McKiernan, View ORCID ProfileErin E. Gray, Caiyun Wu, View ORCID ProfileJohn R. Huguenard, View ORCID ProfileMerritt Maduke, and View ORCID ProfileJ. Du Bois
  1. aDepartment of Chemistry, Stanford University, Stanford, CA 94305;
  2. bDepartment of Molecular & Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305;
  3. cDepartment of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305;
  4. dCharles River Laboratories Cleveland, Inc., Cleveland, OH 44128

See allHide authors and affiliations

PNAS December 22, 2020 117 (51) 32711-32721; first published December 4, 2020; https://doi.org/10.1073/pnas.2009977117
Anna K. Koster
aDepartment of Chemistry, Stanford University, Stanford, CA 94305;
bDepartment of Molecular & Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna K. Koster
Austin L. Reese
cDepartment of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Austin L. Reese
Yuri Kuryshev
dCharles River Laboratories Cleveland, Inc., Cleveland, OH 44128
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianlan Wen
bDepartment of Molecular & Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keri A. McKiernan
aDepartment of Chemistry, Stanford University, Stanford, CA 94305;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Keri A. McKiernan
Erin E. Gray
aDepartment of Chemistry, Stanford University, Stanford, CA 94305;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erin E. Gray
Caiyun Wu
dCharles River Laboratories Cleveland, Inc., Cleveland, OH 44128
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John R. Huguenard
cDepartment of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John R. Huguenard
  • For correspondence: john.huguenard@stanford.edu maduke@stanford.edu jdubois@stanford.edu
Merritt Maduke
bDepartment of Molecular & Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Merritt Maduke
  • For correspondence: john.huguenard@stanford.edu maduke@stanford.edu jdubois@stanford.edu
J. Du Bois
aDepartment of Chemistry, Stanford University, Stanford, CA 94305;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. Du Bois
  • For correspondence: john.huguenard@stanford.edu maduke@stanford.edu jdubois@stanford.edu
  1. Edited by Richard W. Aldrich, The University of Texas at Austin, Austin, TX, and approved October 22, 2020 (received for review May 21, 2020)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Significance

The CLC-2 ion channel facilitates selective passage of Cl– ions across cell membranes. In the central nervous system, CLC-2 is expressed in both neurons and glia and is proposed to regulate electrical excitability and ion homeostasis. CLC-2 has been implicated in various central nervous system disorders, including certain types of epilepsy and leukodystrophy. Establishing a causative role for CLC-2 in neuropathologies, however, has been limited by the absence of selective reagents that enable acute and specific channel modulation. Our studies have resulted in the identification of a highly potent, small-molecule inhibitor that enables specific block of CLC-2 Cl– currents in hippocampal brain slices. This precise molecular tool should enable future efforts to identify and treat CLC-2–related disease.

Abstract

CLC-2 is a voltage-gated chloride channel that is widely expressed in mammalian tissues. In the central nervous system, CLC-2 appears in neurons and glia. Studies to define how this channel contributes to normal and pathophysiological function in the central nervous system raise questions that remain unresolved, in part due to the absence of precise pharmacological tools for modulating CLC-2 activity. Herein, we describe the development and optimization of AK-42, a specific small-molecule inhibitor of CLC-2 with nanomolar potency (IC50 = 17 ± 1 nM). AK-42 displays unprecedented selectivity (>1,000-fold) over CLC-1, the closest CLC-2 homolog, and exhibits no off-target engagement against a panel of 61 common channels, receptors, and transporters expressed in brain tissue. Computational docking, validated by mutagenesis and kinetic studies, indicates that AK-42 binds to an extracellular vestibule above the channel pore. In electrophysiological recordings of mouse CA1 hippocampal pyramidal neurons, AK-42 acutely and reversibly inhibits CLC-2 currents; no effect on current is observed on brain slices taken from CLC-2 knockout mice. These results establish AK-42 as a powerful tool for investigating CLC-2 neurophysiology.

  • chloride channel
  • CLC-2
  • inhibitor

Footnotes

  • ↵1To whom correspondence may be addressed. Email: john.huguenard{at}stanford.edu, maduke{at}stanford.edu, or jdubois{at}stanford.edu.
  • Author contributions: A.K.K., A.L.R., Y.K., J.R.H., M.M., and J.D.B. designed research; A.K.K., A.L.R., Y.K., X.W., K.A.M., E.E.G., and C.W. performed research; A.K.K. and E.E.G. contributed new reagents/analytic tools; A.K.K., A.L.R., X.W., J.R.H., M.M., and J.D.B. analyzed data; and A.K.K., M.M., and J.D.B. wrote the paper.

  • Competing interest statement: A.K.K., J.D.B., and M.M. have filed for a patent “Compositions and Methods to Modulate Chloride Ion Channel Activity,” USSN 16/449,021 from the U.S. Patent & Trademark Office, January 16, 2020.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2009977117/-/DCSupplemental.

Data Availability.

All study data are included in the article and supporting information.

Published under the PNAS license.

View Full Text

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

Subscribers, for more details, please visit our Subscriptions FAQ.

Please click here to log into the PNAS submission website.

PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development and validation of a potent and specific inhibitor for the CLC-2 chloride channel
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Development and validation of a potent and specific inhibitor for the CLC-2 chloride channel
Anna K. Koster, Austin L. Reese, Yuri Kuryshev, Xianlan Wen, Keri A. McKiernan, Erin E. Gray, Caiyun Wu, John R. Huguenard, Merritt Maduke, J. Du Bois
Proceedings of the National Academy of Sciences Dec 2020, 117 (51) 32711-32721; DOI: 10.1073/pnas.2009977117

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Development and validation of a potent and specific inhibitor for the CLC-2 chloride channel
Anna K. Koster, Austin L. Reese, Yuri Kuryshev, Xianlan Wen, Keri A. McKiernan, Erin E. Gray, Caiyun Wu, John R. Huguenard, Merritt Maduke, J. Du Bois
Proceedings of the National Academy of Sciences Dec 2020, 117 (51) 32711-32721; DOI: 10.1073/pnas.2009977117
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley

Article Classifications

  • Biological Sciences
  • Pharmacology
Proceedings of the National Academy of Sciences: 117 (51)
Table of Contents

Submit

Sign up for Article Alerts

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Materials and Methods
    • Data Availability.
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Setting sun over a sun-baked dirt landscape
Core Concept: Popular integrated assessment climate policy models have key caveats
Better explicating the strengths and shortcomings of these models will help refine projections and improve transparency in the years ahead.
Image credit: Witsawat.S.
Model of the Amazon forest
News Feature: A sea in the Amazon
Did the Caribbean sweep into the western Amazon millions of years ago, shaping the region’s rich biodiversity?
Image credit: Tacio Cordeiro Bicudo (University of São Paulo, São Paulo, Brazil), Victor Sacek (University of São Paulo, São Paulo, Brazil), and Lucy Reading-Ikkanda (artist).
Syrian archaeological site
Journal Club: In Mesopotamia, early cities may have faltered before climate-driven collapse
Settlements 4,200 years ago may have suffered from overpopulation before drought and lower temperatures ultimately made them unsustainable.
Image credit: Andrea Ricci.
Steamboat Geyser eruption.
Eruption of Steamboat Geyser
Mara Reed and Michael Manga explore why Yellowstone's Steamboat Geyser resumed erupting in 2018.
Listen
Past PodcastsSubscribe
Birds nestling on tree branches
Parent–offspring conflict in songbird fledging
Some songbird parents might improve their own fitness by manipulating their offspring into leaving the nest early, at the cost of fledgling survival, a study finds.
Image credit: Gil Eckrich (photographer).

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490